Latest Vaccine News

Discussion in 'Politics' started by gwb-trading, Apr 24, 2020.

  1. UsualName

    UsualName

    #1661     Sep 30, 2021
    gwb-trading likes this.
  2. Mercor

    Mercor

    Melbourne cases hit record despite two months of lockdown
     
    #1662     Sep 30, 2021
  3. gwb-trading

    gwb-trading

    So do tell... what is the record. Oh... the entire f@cking country of Australia hit 1700 daily cases. What a shame.

    Many freaking counties in the U.S. with much lower populations that the entire f@cking country of Australia have been having more daily cases than this for months.

    While you are at it tell us how the number of Covid deaths per capita is doing in Australia compared to the U.S.
     
    #1663     Sep 30, 2021
  4. Mercor

    Mercor

    I agree the number is small, to small to shut down a country...
    Its the trend that is the problem
    When a politician makes a decision to shut down and take away liberties, and problem gets worst, that power needs to be reviewed
     
    #1664     Sep 30, 2021
  5. gwb-trading

    gwb-trading

    Despite a small number of loud lockdown protestors in Australia --- the majority of the population in the country supports the country's "Zero Covid" policy with mitigations and restrictions when Covid appears.

    You should note that over time Australia has had much less time with restrictions or lockdowns in place than most other countries including the U.S.
     
    #1665     Sep 30, 2021
  6. Bugenhagen

    Bugenhagen

    Colombia went with extending vaccine dose gap to 12 weeks (though elderly / high risk were done on a 3 week basis) and the decoupling of infections and deaths is remarkable. Of course 100 percent masking is still in force as as well. This has had a huge benefit, just wear a mask in public, no off-on confusion for kids and forgetful.

    Extending Time Between Covid-19 Vaccine Doses Affords Benefits
    https://www.minsalud.gov.co/English...-Covid-19-Vaccine-Doses-Affords-Benefits.aspx
     
    Last edited: Sep 30, 2021
    #1666     Sep 30, 2021
    gwb-trading and UsualName like this.
  7. UsualName

    UsualName

    Absolutely mind blowing numbers…

    12945E76-B268-488C-9520-2E83821E4BA0.jpeg
     
    #1667     Oct 1, 2021
    wrbtrader likes this.
  8. gwb-trading

    gwb-trading

    Coronavirus: Pfizer booster may better protect than third CoronaVac shot, finds Turkish study
    • Researchers at Manisa Celal Bayar University studied several hundred health workers vaccinated with CoronaVac, with boosters beginning in July
    • China began rolling out Covid-19 boosters in several provinces this month and overseas countries are supplementing the CoronaVac regimen with other vaccines
    https://www.scmp.com/news/china/sci...er-booster-may-better-protect-third-coronavac

    (More at above url)
     
    #1668     Oct 2, 2021
  9. gwb-trading

    gwb-trading

    AstraZeneca says its COVID-19 vaccine was 74 percent effective in US testing
    https://thehill.com/policy/healthca...neca-says-its-covid-19-vaccine-was-74-percent

    British drugmaker AstraZeneca's COVID-19 vaccine Vaxzevria has been found to have a 74 percent efficacy in preventing symptomatic disease, according to a report published Wednesday in the New England Journal of Medicine.

    The report, which studied more than 26,000 volunteers in the United States, Chile and Peru, also found the vaccine had an 83.5 percent efficacy rate in people ages 65 and older.

    The AstraZeneca vaccine has not been approved for use in the United States, though it has been exported from the U.S. for use abroad.

    Vaxzevria is currently authorized in more than 170 countries, with the company seeking U.S. approval later this year.

    In July, AstraZeneca looked to get U.S. approval from the Food and Drug Administration rather than receive emergency authorization, according to The Associated Press.

    The 74 percent efficacy rate was lower than the initial 79 percent reported by AstraZeneca in March, which was later revised to 76 percent after health officials said the figure was based on "outdated information."

    There were no severe or critical symptomatic cases of COVID-19 in the more than 17,600 participants who tested positive, compared with eight severe cases among the 8,500 volunteers who received the placebo. The placebo also saw two deaths, but not among those who received the vaccine.

    "I was pleasantly surprised," Anna Durbin, a vaccine researcher at Johns Hopkins University and one of the study's investigators, told Reuters. "It was also highly protective against severe disease and hospitalization."

    While blood clots were one of the first serious side effects of the vaccine, there were no cases of them in the study group.

    The company is still exploring the need for booster doses on those who have already been vaccinated from either its own shot or other mRNA-based vaccines like Pfizer and Moderna, Reuters noted.
     
    #1669     Oct 3, 2021
  10. gwb-trading

    gwb-trading

    #1670     Oct 4, 2021